These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [ON THE MECHANISM OF ACTION OF FIBRINOLYTIC SUBSTANCES]. ROSOLLECK H Thromb Diath Haemorrh; 1963 Jul; 143():459-71. PubMed ID: 14081267 [No Abstract] [Full Text] [Related]
23. Fibrinolytic therapy of coronary thrombosis. Controlled trial of 75 cases. DEWAR HA; STEPHENSON P; HORLER AR; CASSELLS-SMITH AJ; ELLIS PA Br Med J; 1963 Apr; 1(5335):915-20. PubMed ID: 14027424 [No Abstract] [Full Text] [Related]
24. [PRESENT STATUS OF THROMBOLYTIC THERAPY]. VAIREL EG; ANTOINE G Sangre (Barc); 1964; 41():441-6. PubMed ID: 14248832 [No Abstract] [Full Text] [Related]
25. Human fibrinolysin with and without urokinase: its effect on experimental arterial thrombi in dogs. ROSCHLAU WH; PAINTER RH Can J Biochem Physiol; 1962 Dec; 40():18-9-38. PubMed ID: 13974768 [No Abstract] [Full Text] [Related]
26. Endogenous release of plasminogen activator from gastric juice by orally given streptokinase. INNERFIELD I; HOCHBERG R Curr Ther Res Clin Exp; 1962 Oct; 4():524-8. PubMed ID: 13956568 [No Abstract] [Full Text] [Related]
27. [THERAPEUTIC FIBRINOLYSIS. I. STUDIES ON THE EFFECTS OF STREPTOKINASE AND ACTASE IN VITRO]. JUERGENS J Klin Wochenschr; 1964 Jun; 42():534-8. PubMed ID: 14233281 [No Abstract] [Full Text] [Related]
28. FIBRINOLYSIS AND FIBRINOLYTIC AGENTS IN CLINICAL PRACTICE. (WITH SPECIAL REFERENCE TO STREPTOKINASE). JAMES DC; BROWSE NL Br J Clin Pract; 1964 Jun; 18():343-56. PubMed ID: 14169065 [No Abstract] [Full Text] [Related]
29. [THERAPEUTIC FIBRINOLYSIS. II. STUDIES ON THE EFFICACY OF STREPTOKINASE AND ACTASE IN VIVO]. JUERGENS J Klin Wochenschr; 1964 Jun; 42():539-46. PubMed ID: 14233282 [No Abstract] [Full Text] [Related]
31. The combined use of fibrinolytic and anticoagulant agents. Laboratory and clinical considerations. MOSER KM; HAJJAR GC Am J Cardiol; 1960 Aug; 6():496-502. PubMed ID: 13773043 [No Abstract] [Full Text] [Related]
32. Thrombolytic therapy. MCNICOL GP Proc R Soc Med; 1963 May; 56(5):414-8. PubMed ID: 13932243 [No Abstract] [Full Text] [Related]
33. Standardization of fibrinolytic preparations. Measurement of proteolytic and activator activity of streptokinase-activated human plasminogen. BAUMGARTEN W; CIMINERA JL; VAN PELT SM J Pharm Sci; 1962 Apr; 51():314-7. PubMed ID: 13865955 [No Abstract] [Full Text] [Related]
34. [THROMBOLYTIC THERAPY. CLINICAL TRIALS OF TREATMENT WITH PURIFIED STREPTOKINASE]. ABASTADO M Bull Mem Soc Med Hop Paris; 1964 Jul; 115():941-57. PubMed ID: 14230879 [No Abstract] [Full Text] [Related]
35. CURRENT APPRAISAL OF THROMBOLYTIC THERAPY. A CRITICAL REVIEW. LIEBERMAN J Calif Med; 1963 Nov; 99(5):301-7. PubMed ID: 14081772 [TBL] [Abstract][Full Text] [Related]
37. Formation and properties of the activator of plasminogen and of human and bovine plasmin. MULLERTZ S Biochem J; 1955 Nov; 61(3):424-34. PubMed ID: 13269378 [No Abstract] [Full Text] [Related]
38. A STANDARD CLOT METHOD FOR THE ASSAY OF PLASMINOGEN ACTIVATORS, ANTI-ACTIVATORS, AND PLASMIN. HAWKEY CM; STAFFORD JL J Clin Pathol; 1964 Mar; 17(2):175-81. PubMed ID: 14149945 [TBL] [Abstract][Full Text] [Related]
39. THE EFFECT OF HEPARIN ON FIBRINOLYTIC ACTIVATORS AND PLASMIN. NILSSON IM; BIELAWIEC M; BJOERKMAN SE Scand J Haematol; 1964; 1():75-88. PubMed ID: 14175721 [No Abstract] [Full Text] [Related]
40. THE ROLE OF FIBRINOLYSIS IN THE TREATMENT OF ARTERIAL THROMBOSIS: EXPERIMENTAL AND CLINICAL ASPECTS. TSAPOGAS MJ Ann R Coll Surg Engl; 1964 May; 34(5):293-313. PubMed ID: 14145330 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]